Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The proto-oncogene tyrosine-protein kinase ROS1 is a receptor tyrosine kinase involved in epithelial cell differentiation and regionalization. Oncogenic fusions involving ROS1 are found in various cancers, particularly non-small cell lung cancer (NSCLC), where they drive tumorigenesis. Targeted therapies like repotrectinib have been developed to inhibit ROS1 kinase activity in cancers harboring ROS1 alterations.
Inhibition of ROS1 kinase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene Tyrosine-Protein Kinase ROS1 (ROS1).